Sichuan Kelun Pharmaceutical Co Ltd(002422) News

Date	Title
Apr 24	Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting
Oct 23	Merck discontinues some cancer drug development with China's Sichuan Kelun